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1. Introduction 
When growing E. coli cells are subjected to 
unfavourable conditions they accumulate S’-diphospho- 
guanosine-3’-diphosphate (ppGpp or MS I) and 5’-tri- 
phospho-guanosine-3’-diphosphate (pppGpp or MS II). 
Simultaneously a number of metabolic changes can be 
observed [ 11. 
Synthesis of guanosine polyphosphates depends on 
the existence of the stringent factor which is the 
product of relA gene [2]. As has been proved by in 
vitro experiments, stringent factor - stimulated by 
mRNA and by the codon specific uncharged tRNA 
bound to the ribosomal acceptor site - together with 
the 70s ribosome synthesizes ppGpp and pppGpp 
from GDP or GTP substrates [3] . Stringent factor 
itself is also able to catalyze a slight synthesis of 
guanosine polyphosphates which may be increased 
manyfold by adding 20% methanol to the reaction 
mixture [4]. 
Here we present a new evidence that the post- 
ribosomal fraction contains an enzyme which 
synthesizes pppGpp only. The enzyme is equally found 
in relA’, relA- and SPOT- strains. The pppGpp 
synthesizing activity described by us - when com- 
pared and referred to the same cell mass of the 
stringent factor dependent guanosine polyphosphate 
synthesizing activity of relA’ strain - was at least 
10% of it. 
2. Materials and methods 
The following strains were used in our experiments: 
E. coli B (prototroph), E. coli CP 99 (relA’, SPOT’, 
North-Holland fiblishing Company - Amsterdam 
Arg-, His-, Ser-, B; ), E. coli CP 100 (relA_, SPOT’, 
Arg-, His-, Ser-, BY), E. coli NF 161 (relA’, SPOT-, 
Arg-, His-, Met-). Strains were tested for their 
RNA synthesis ( [ 3H] uridine incorporation) and 
guanosine polyphosphate synthesizing activity during 
normal and amino acid starved growing conditions. 
Culture media contained 15.1 g NazHP04.1 2 HaO, 
3.0 g KH2P04, 3.0 g NaCl, 2.0 g Na-citrate, 4.0 g 
casein hydrolysate, 4.0 g yeast extract, 4.0 g glucose 
per litre. pH was adjusted to 7.2, cells were grown at 
37°C and vigorous aeration was achieved by using a 
horizontal shaker. Growth was stopped at Ass5 nrn = 
2/ml by centrifuging the cells at 5000 g at 0°C. 
Bacterial paste was washed with 0.15 M KC1 and 
stored at -30°C. 
2.1. Preparation of postribosomal supernatant 
Each step was carried out at 0-2°C. Frozen 
bacterial paste was ground thoroughly with 1.6 parts 
Al*Oa (Sigma type 305), suspended in a buffer con- 
taining 0.01 M Tris-HCl pH 7.8, 0.01 M MgClz, 
7.1 Om3 M fi-mercaptoethanol and centrifuged at 
25 000 g. Supernatant was centrifuged again at 
150 000 g (Beckman 60Ti rotor) and to the super- 
natant fraction streptomycin sulphate was added to 
1.5% final concentration. The turbid solution was 
centrifuged at 25 OOOg. The supernatant was saturated 
to 75% with ammonium sulphate, pelleted at 25 000 g 
and the precipitate dissolved in a minimal volume of 
buffer containing 20 mM Tris-HCl pH 7.8, 50 mM 
KCl, 1 .O mM MgCla, 0.2 mM EDTA, 5.0% glycerol, 
7.0 mM fl-mercaptoethanol. The solution was dialyzed 
overnight against the same buffer and diluted to 
2 mg/ml protein content. Dialyzate was assayed for 
its nucleotide polyphosphate synthesizing capacity. 
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2.2. Reaction mixture of the in vitro polyphosphate 
synthesizing assay system 
Tris-acetate, pH 7.8, 100 mM, NH,-acetate 20 mM, 
Mg-acetate 10 mM, K-acetate 10 mM, dithiothreitol 
10 mM, GDP or GTP 2.0 mM [y-32P]ATP 0.16 mM 
(200 mCi/mM) and 2 1.11 of enzyme solution in 50 ~1 
final volume. After 3 min preincubation at 37°C the 
reaction was started by adding [Y-~*P] ATP. Incuba- 
tion period: 10 min at 37°C. Reaction was stopped 
by adding 5 ~1200 mM EDTA (pH 7.2). 5 ~1 of this 
solution was spotted onto polyethyleneimine cellulose 
(PEI) thin-layer plates (MN-300 PEI, Macherey-Nagel) 
and dried. Chromatograms were developed in 1.5 M 
K-phosphate pH 3.4 [5], dried again and autoradio- 
graphed. Spots with the corresponding R, values were 
cut out and counted by liquid scintillation counting. 
[Y-~*P] ATP was prepared by the method of Avron 
[7]. Nucleoside di- and triphosphates were purchased 
from REANAL (Budapest), carrier-free 32P isotope 
from the Isotope Institute of the Hungarian Academy 
of Sciences. 
32P-labelled authentic pppGpp was prepared from 
His, Arg-starved CP 99 strain adopting the method of 
Lazzarini and Cashel [6] . 
3. Results 
Using the procedure reported in Materials and 
methods the postribosomal supernatant preparations 
t 
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Fig. 1. Dependence ofpppGpp formation on enzyme concentra- 
tion. In 50 ~1 final volume Tris-acetate 100 mM, pH 7.8, 
NH,-acetate 20 mM, Mg-acetate 10 mM, K-acetate 10 mM, 
dithiothreitol 10 mM, GDP 2.0 mM, [y-3*P]ATP 0.16 mM 
(200 mCi/mmol) and amounts of E. coli B enzyme as indicated. 
Incubation for 10 min at 37°C. 
have a considerable pentaphosphate synthesizing 
activity which is proportional to the protein con- 
centration (fig. 1). The synthesis has an optimum 
The substrate specificity of the reaction was also 
demonstrated. Among the nucleoside diphosphates 
(ADP, UDP, CDP, GDP) tested in our experiments, 
concentration for Mg*’ and NH: in the ranges of 
only GDP can serve as phosphate acceptor. GTP seems 
to be a much weaker acceptor. 
2-20 mM and lo-30 mM, respectively. 
pppGpp synthesized in our system cannot be 
Table 1 
Stringent factor-independent pppGpp synthesis in E. coli strains 
Strain Substrate 32P incorporated into pppGpp 
(pmoles/pg protein X min) 
E. coli B GDP 12.3 
E. coli Cp 99 
GTP 0.1 
GDP 16.7 
E coli Cp 100 
GTP 
GDP 
0.4 
11.5 
E. coli NF 161 
GTP 0.6 
GDP 7.2 
GTP 0.5 
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Table 2 
Effect of antibiotics on stringent factor independent pppGpp synthesizing system 
~__ 
Antibiotics 32P incorporated into pppGpp 
(pmoles/ng protein X mm) 
Without antibiotic 11.6 
Dimethylsulphoxide 2% 11.8 
Thiostrepton 20 PM 11.4 
Oxytetracycline 200 fig/ml 9.2 
Streptomycin 400 ng/ml 14.2 
Kanamycin 400 Mg/ml 12.1 
Erythromycin 400 pg/ml 11.8 
Thiostrepton, oxytetracycline and erythromycin were dissolved in dimethyl- 
sulphoxide. Final concentration of dimethylsulphoxide in the reaction 
mixture: 2%. 
distinguished chromatographically from that produced 
by the authentic E. coli strain. Data in table 1 
demonstrate that pppGpp is produced with the same 
efficiency by the postribosomal supernatant fraction 
of each strain tested, including the relA_ and SPOT- 
ones. 
Ribosome-dependent polyphosphate synthesis can 
be inhibited by thiostrepton (which inhibits the 
translocating step in protein synthesis) even at 2.0 PM 
concentration as well as by oxytetracycline 
(200 /Ig/mU 191. 
In table 2 the effect of these and other antibiotics 
inhibiting protein synthesis is demonstrated. As can 
be seen, these antibiotics do not inhibit pppGpp 
synthesis in our system. 
4. Discussion 
We report here the synthesis of pppGpp from GDP 
and ATP by the 75% ammonium sulphate precipitable 
fraction of postribosomal supernatant prepared from 
E. coli. The following data indicate that it is not 
catalyzed by the stringent factor: 
(1) The Mg” and NH; ion optimum concentrations 
differ from those of the ribosomal dependent system [8]. 
(2) The extract prepared from relA_ mutant is as 
effective as its relA’ counterpart (table 1) and the relA 
gene is generally considered to be the structural gene 
of the stringent factor [2]. 
An interesting feature of the reaction described 
here is that pppGpp, and only pppGpp is synthesized 
from GDP and ATP. The explanation of this pheno- 
menon is not yet clear. One possibility is that ppGpp 
is the primary product and it is phosphorylated to 
pppGpp very rapidly. However, this seems unlikely, 
since the extract prepared from the SPOT- mutant, 
which is considered to be defective in ppGpp + pppGpp 
conversion, exerted the same activity as the SPOT’ 
strains [lO,ll] (table 1). 
Another possibility is that first GTP is derived from 
GDP and ATP and it is converted into pppGpp. This 
could agree with the new metabolic scheme of MS 
nucleotide metabolism, according to which ppGpp is 
derived from the pppGpp (Kari, Torok, Travers, 
personal communication). But, then why is not the 
added GTP effective in place of GDP? 
It is known that the relA_ and relA’ strains have 
the same basal level of MS nucleotides during balanced 
growth [6]. The stringent factor-free MS synthesis 
demonstrated here may have some significance in 
explaining this phenomenon. 
Existence of nucleoside polyphosphates in sporulat- 
ing B. subtilis cells [ 121 , isolation and purification of 
the ppGpp synthesizing enzyme from culture filtrate 
of Streptomyces adephospholyticus [ 131 and 
Streptomyces morookaensis [ 141, occurence of 
stringent factor independent synthesis pathway in 
E. coli cells, and the presence of nucleotide poly- 
phosphates in eukaryotic cells [ 15,161 and the fact 
that mitochondrial and chloroplast preparates are able 
to produce nucleoside polyphosphates in vitro [ 171 
call attention to the possible metabolism-regulating 
function of these substances both in prokaryotes and 
eukaryotes. 
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